Ann: Trading Halt, page-105

I see some people viewing the trading halt until Monday as a potential rejection. Some comments describing the situation as ‘If approved then what is the delay?’ Etc etc... I understand that you can argue that point, however, why would they need the weekend to write a report that can be so easily written. There’s not much to it if it’s a rejection. I think it’s more obvious to view it in a way of: the fda HAS provided approval and now MSB has to write the report on the approval (of course) but also how the company will move forward and how the treatment will be implemented in hospitals etc. It’s a longer process than just a straight up ‘it’s been approved’.